PT3365366T - Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection - Google Patents

Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection

Info

Publication number
PT3365366T
PT3365366T PT167944727T PT16794472T PT3365366T PT 3365366 T PT3365366 T PT 3365366T PT 167944727 T PT167944727 T PT 167944727T PT 16794472 T PT16794472 T PT 16794472T PT 3365366 T PT3365366 T PT 3365366T
Authority
PT
Portugal
Prior art keywords
trispecific
prevention
treatment
binding proteins
hiv infection
Prior art date
Application number
PT167944727T
Other languages
Portuguese (pt)
Original Assignee
Sanofi Sa
The Usa As Represented By The Sec Dep Of Health And Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, The Usa As Represented By The Sec Dep Of Health And Human Services filed Critical Sanofi Sa
Publication of PT3365366T publication Critical patent/PT3365366T/en

Links

PT167944727T 2015-10-25 2016-10-24 Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection PT3365366T (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562246113P 2015-10-25 2015-10-25
EP2016305211 2016-02-24
US201662322029P 2016-04-13 2016-04-13
US201662331169P 2016-05-03 2016-05-03

Publications (1)

Publication Number Publication Date
PT3365366T true PT3365366T (en) 2021-10-20

Family

ID=78331214

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167944727T PT3365366T (en) 2015-10-25 2016-10-24 Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection

Country Status (1)

Country Link
PT (1) PT3365366T (en)

Similar Documents

Publication Publication Date Title
HK1253385A1 (en) Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection
IL262241A (en) Trispecific and/or trivalent binding proteins
HK1253882A1 (en) Methods and compositions for rna-guided treatment of hiv infection
HK1251554A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
HK1248711A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
IL253243A0 (en) Combined preparations for the treatment of cancer or infection
ZA201705634B (en) Quinoline derivatives for use in the treatment or prevention of viral infection
HK1258276A1 (en) Compounds and combinations for the treatment of hiv
HK1250480A1 (en) Compositions and methods for the treatment of hbv infection
IL263368A (en) Prevention and treatment of viral infections
HK1252343A1 (en) Compositions and methods for the treatment of viral infection
ZA202006103B (en) Trispecific and/or trivalent binding proteins
PL3183003T3 (en) Methods for prevention and/or treatment of infection
EP3538108A4 (en) Methods of treating and inhibiting ebola virus infection
GB201615035D0 (en) Treatment and prevention of viral infection
SG10202003467RA (en) Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection
PT3365366T (en) Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infection
EP3219323A4 (en) Pharmaceutical composition for treatment and/or prevention of hepatitis c
ZA201806629B (en) Trispecific and/or trivalent binding proteins
GB201519483D0 (en) Prevention and treatment of microbial infections
GB201518252D0 (en) Prevention and treatment of microbial infections
GB201513047D0 (en) Prevention and treatment of microbial infections
GB201511576D0 (en) Prevention and treatment of microbial infections
GB201509654D0 (en) Prevention and treatment of microbial infections
GB201508313D0 (en) Prevention and treatment of microbial infections